Regulation of 1,25-Dihydroxyvitamin D3Production by Cultured Alveolar Macrophages from Normal Human Donors and from Patients with Pulmonary Sarcoidosis*
- 1 December 1987
- journal article
- research article
- Published by The Endocrine Society in Journal of Clinical Endocrinology & Metabolism
- Vol. 65 (6) , 1201-1209
- https://doi.org/10.1210/jcem-65-6-1201
Abstract
Regulation of the production of the biologically active vitamin D3 sterol 1,25-dihydroxyvitamin D3 [1,25-(OH)2D3] by cultured pulmonary alveolar macrophages (PAM) obtained from 6 patients with pulmonary sarcoidosis and from 9 normal subjects was studied. The sarcoid cells, all collected from patients with normal calcium metabolism, synthesized 1,25-(OH)2-[3H]D3 from the substrate 25-hydroxyvitamin [3H] D3 (25OH-[3H]D3), whereas in vitro incubation with recombinant human interferon-.gamma. (IFN.gamma.) or lipopolysaccharide (LPS) was required for induction of synthesis of the hormone by normal PAM. Exogenous 1,25-(OH)2D3 (10-100 nmol/L) decreased endogenous hormone production by normal PAM by approximately 45%. The relative inhibitory effect of 1,25-(OH)2D3 was less pronounced in sarcoid PAM in which 10-100 nmol/L 1,25-(OH)2D3 inhibited 250HD3-1-hydroxylase by approximately 25%. An accompanying induction of the 250HD3-24-hydroxylase, which is typical for renal cells, was found at low levels in only 3 of 10 experiments; in this regard, no differences between sarcoid and normal PAM were apparent. PTH or forskolin did not influence 250HD3 metabolism by PAM. 1,25-(OH)2D3 production by sarcoid PAM was enhanced by lipopolysaccharide and IFN.gamma.. Likewise, recombinant human interleukin-2 stimulated 1,25-(OH)2D3 production by sarcoid PAM, suggesting a possible role for both IFN.gamma. and interleukin-2 in the induction of 1,25-(OH)2D3 synthesis by sarcoid PAM in vivo. Recombinant human IFN.alpha., IFN.beta., and granulocyte-macrophage colony-stimulating factor had little effect. Dexamethasone and chloroquine which have in vivo antihypercalcemic activity in sarcoidosis, both inhibited 1,25-(OH)2D3 synthesis by sarcoid PAM; chloroquine simultaneously stimulated the 24-hydroxylase. Our studies suggest that 250HD3-metabolizing system in PAM is in some respects different from renal metabolism of 250HD3.This publication has 26 references indexed in Scilit:
- Vitamin D Conversion by Sarcoid Lymph Node HomogenateAnnals of Internal Medicine, 1984
- Normocalcemia in a Hypoparathyroid Patient with Sarcoidosis: Evidence for Parathyroid-Hormone-Independent Synthesis of 1,25 Dihydroxyvitamin DAnnals of Internal Medicine, 1983
- Regulation of 25 Hydroxyvitamin D31-Hydroxylase in Serum-Free Monolayer Culture of Mouse KidneyEndocrinology, 1982
- T cell growth factor receptors. Quantitation, specificity, and biological relevanceThe Journal of Experimental Medicine, 1981
- Evidence that Increased Circulating 1α,25-Dihydroxyvitamin D is the Probable Cause for Abnormal Calcium Metabolism in SarcoidosisJournal of Clinical Investigation, 1979
- Regulation of the metabolism of 25-hydroxyvitamin D3 in primary cultures of chick kidney cells.Journal of Clinical Investigation, 1979
- Regulation of the hydroxylation of 25-hydroxyvitamin D3 in vivo and in primary cultures of chick kidney cells.Journal of Biological Chemistry, 1979
- 1, 25-DIHYDROXYCHOLECALCIFEROL IN THE PATHOGENESIS OF THE HYPERCALCÆMIA OF SARCOIDOSISThe Lancet, 1979
- Effect of oestrogen and 1,25-dihydroxycholecalciferol on 25-hydroxycholecalciferol metabolism in primary chick kidney-cell culturesBiochemical Journal, 1978
- CONCEPT OF ACTIVATED MACROPHAGE1978